Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 3

1.

Adoptive transfer of tumor-specific Tc17 effector T cells controls the growth of B16 melanoma in mice.

Garcia-Hernandez Mde L, Hamada H, Reome JB, Misra SK, Tighe MP, Dutton RW.

J Immunol. 2010 Apr 15;184(8):4215-27. doi: 10.4049/jimmunol.0902995. Epub 2010 Mar 17.

2.

Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinic.

Majchrzak K, Nelson MH, Bailey SR, Bowers JS, Yu XZ, Rubinstein MP, Himes RA, Paulos CM.

Cancer Immunol Immunother. 2016 Mar;65(3):247-59. doi: 10.1007/s00262-016-1797-6. Epub 2016 Jan 29. Review.

3.

IL-17A-producing CD8(+)T cells as therapeutic targets in autoimmunity.

Liang Y, Pan HF, Ye DQ.

Expert Opin Ther Targets. 2015 May;19(5):651-61. doi: 10.1517/14728222.2014.997710. Epub 2015 Jan 22. Review.

PMID:
25611933

Supplemental Content

Support Center